Month: May 2022

Record First Quarter Net Sales, Gross Margin, Net Income and Adjusted EBITDA Net sales of $5.7 billion increased 36.1%Core Organic Sales Growth of 15.0%Net income increased 270.6% to $639.6 millionAdjusted EBITDA increased 119.8% to $1.0 billionAcquired Two Value-Added Companies in April$2 Billion Share Repurchase Authorization DALLAS, May 10, 2022 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (NYSE: BLDR) today reported its results for the first quarter ended March 31, 2022. First Quarter 2022 BFS Highlights All Year-Over-Year Comparisons Unless Otherwise Noted:Net sales of $5.7 billion for the quarter increased 36.1% driven by double-digit core organic growth, commodity inflation and acquisitions. Net income grew 270.6% to $639.6 million, or $3.56 per diluted share, and adjusted net income increased 136.5% to $700.8 million,...

DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for three months ended April 2, 2022. Q1 Financial Summary & Recent Highlights:Net Sales of $117.3 million, up $35.5 million, or 43.4%, year over year as reported and 8.6% organically* Net Loss of ($14.8) million, compared to Net Income of $24.5 million in prior-year period Adjusted EBITDA* of $7.1 million, compared to $11.1 million in prior-year period“We are pleased with our strong start to the year as we continue to build our market penetration and drive growth despite a challenging macro environment. Our commercial organization executed well, and we saw progress with our integration plans,” commented...

– Entered exclusive global license and collaboration agreement with Jazz Pharmaceuticals to develop and commercialize WTX-613; received $15.0M upfront payment and eligibility for up to $1.26B in downstream milestones as well as royalties on potential future sales – – Presented promising preclinical data on two lead INDUKINE™ molecules, WTX-124 and WTX-330, at AACR 2022; investigational new drug (IND) applications on track for both programs – – Q1 cash balance of $143.7 million; together with access to non-dilutive capital, provides runway through at least the fourth quarter of 2023 – CAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated...

Company Becomes First Major Cruise Operator to Return Entire Fleet Back to Service Pricing Strength Continues for all Future Periods Operating Cash Flow Slightly Positive in March MIAMI, May 10, 2022 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings”, “Norwegian” or the “Company”) today reported financial results for the first quarter ended March 31, 2022 and provided a business update. “Last week we reached the biggest milestone yet in our Great Cruise Comeback as Norwegian Spirit, the last ship in our fleet to resume sailing, welcomed guests on board in Papeete, Tahiti. The herculean effort to restart our fleet would not have been possible without the incredible fortitude of the entire Norwegian team and the unwavering support of our key partners...

Total Revenue up 14% Year-Over-Year to $33.2 Million and High Margin, Recurring and Services Revenue up 7% Year-Over-Year to $18.8 million WOODCLIFF LAKE, N.J., May 10, 2022 (GLOBE NEWSWIRE) — PowerFleet, Inc. (Nasdaq: PWFL), a global leader of SaaS-based data insight solutions that manage enterprise assets for seamless business operations, reported results for the first quarter ended March 31, 2022. First Quarter 2022 Financial HighlightsTotal revenue was $33.2 million, up 14% year-over-year. High margin, recurring and services revenue increased 7% year-over-year to $18.8 million, or 57% of total revenue. $20.9 million in cash and cash equivalents and working capital of $40.5 million at quarter-end.Management Commentary “The first quarter marked a solid start to the year, highlighted by 14% year-over-year revenue growth,”...

Initial bezuclastinib APEX data to be presented at the European Hematology Association (EHA) 2022 Annual Congress Building a portfolio of discovery stage programs, creating potential best-in-class small molecule kinase inhibitors for genetically defined oncology indications and rare diseases Ended 1Q 2022 with $191.0 million in cash, sufficient to fund operations into 2024 CAMBRIDGE, Mass. and BOULDER, Colo., May 10, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the first quarter ended March 31, 2022. “We continue to make significant progress towards our strategic priorities for 2022,” said Andrew Robbins, President and CEO of Cogent Biosciences. “We look forward to presenting...

Reported sales +4.5% compared to prior year; Acquisition adjusted constant currency +7.0%Food and Beverage reported sales +14.8% compared to prior year Institutional reported sales +0.9% compared to prior year Institutional base sales excluding infection prevention +26% compared to prior yearNet Loss attributable to common stockholders of $39.7 million for the first quarterAdjusted EBITDA was $60.3 million, representing margins of 9.1%Reaffirms 2022 Adjusted EBITDA outlook to range from $380 to $420 million with full year revenue growth of high single digitsFORT MILL, S.C., May 10, 2022 (GLOBE NEWSWIRE) — Diversey Holdings, Ltd. (“Diversey”) (NASDAQ: DSEY) announces first quarter results. “We delivered a solid quarter with strong and broad-based top line growth, driven by accelerating pricing and new...

KING OF PRUSSIA, Pa., May 10, 2022 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced financial results for its first quarter ended March 31, 2022. “We delivered strong performance in the first quarter, with outstanding execution from our teams around the world,” said David DeStefano, Vertex Chief Executive Officer. “Our revenues continue to accelerate, and the investments we are making to drive our growth strategy are gaining momentum and advancing our market leadership.” First Quarter 2022 Financial ResultsTotal revenues of $115.0 million, up 17.0% year-over-year. Software subscription revenues of $97.1 million, up 16.6% year-over-year. Cloud revenues of $38.3 million, up 42.1% year-over-year. Annual Recurring Revenue (“ARR”) of $380.6 million,...

NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Kaltura, Inc (Nasdaq: KLTR) in the Consolidated Statement of Operations for the three months ended March 31 2021, under “Other operating expenses” there should have been 1,724 instead of a blank. All other numbers remain the same. The corrected release follows: Kaltura, Inc. (“Kaltura” or the “Company”), the video experience cloud, today announced financial results for the first quarter ended March 31, 2022, as well as outlook for the second quarter and full year 2022. “Kaltura’s first quarter revenue and adjusted EBITDA exceeded the high end of our guidance range,” said Ron Yekutiel, Co-founder, Chairman and Chief Executive Officer of Kaltura. “We continue to believe that our exciting new lower-touch and self-serve...